Experimental hepatitis B drug might offer ‘functional cure’ for a subset of patients

WASHINGTON (AP) — A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers reported Thursday. In two international studies, about 1 in 5 patients given the experimental drug sa...

Redirecting to full article...